Literature DB >> 6329512

Screening procedure for the development of mammary tumour-inhibiting anti-oestrogens.

R W Hartmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329512     DOI: 10.1016/0305-7372(84)90055-0

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  2 in total

1.  Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.

Authors:  W Schwarz; R W Hartmann; J Engel; M R Schneider; H Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Anti-proliferative effects of 1,2-diphenylethane oestrogens and anti-oestrogens on human breast cancer cells.

Authors:  R W Hartmann; T Sinchai; G Kranzfelder
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.